'Excipient' presentation slideshows

683 views • 30 slides

Welcome

PQRI Survey of Pharmaceutical Excipient Testing and Control Strategies Used by Excipient Manufacturers, Excipient Distributors and Drug-Product Manufacturers. When? The time is NOW! The next 2 days provide the opportunity for you to participate! Please be respectful of time limits.

299 views • 29 slides

Moderator: Barbara Ferguson Scribes: Catherine Sheehan Dr. Hong Wang

Discuss the Strategies to Increase the Number of Excipients Labeled USP-NF October 10-11, 2006 DISCUSSION TOPIC D Closing Presentation. Moderator: Barbara Ferguson Scribes: Catherine Sheehan Dr. Hong Wang. 1.a. What are the barriers to labeling an excipient as USP-NF grade?

244 views • 17 slides

Moderator: Barbara Ferguson Scribes: Catherine Sheehan Dr. Hong Wang

Discuss the Strategies to Increase the Number of Excipients Labeled USP-NF October 10-11, 2006 DISCUSSION TOPIC D Closing Presentation. Moderator: Barbara Ferguson Scribes: Catherine Sheehan Dr. Hong Wang. 1.a. What are the barriers to labeling an excipient as USP-NF grade?

176 views • 17 slides

Atypical Actives PDA-FDA Conference March 9-10, 2011

Atypical Actives PDA-FDA Conference March 9-10, 2011. David R. Schoneker Email: dschoneker@colorcon.com. What is an Atypical Active ?.

233 views • 15 slides

Atypical Actives PDA-FDA Conference March 9-10, 2011

Atypical Actives PDA-FDA Conference March 9-10, 2011. David R. Schoneker Email: dschoneker@colorcon.com. What is an Atypical Active ?.

166 views • 15 slides

PQRI Workshop Discussion D

Discuss Strategies to Increase the Number of Excipients Labeled USP-NF. PQRI Workshop Discussion D. Current Situation Increasing danger that excipient manufacturers will stop producing excipients that meet USP-NF standards May result in deletion of USP-NF monograph for such excipients.

131 views • 12 slides